Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Signal Twitter WhatsApp YouTube

Caroline Chen

Reporter

Caroline Chen covers health care for ProPublica. Previously, she worked at Bloomberg News, where she wrote about Valeant Pharmaceutical’s use of a mail order pharmacy to boost reimbursements for its drugs, the tactics used by a rare disease drugmaker to scare patients into staying on therapy, and the plight of medically complex babies who get stranded in hospitals because of a lack of home-care nurses. She received her Master’s degree from the Stabile Program in Investigative Journalism at Columbia University, where she was awarded a Pulitzer Traveling Fellowship.

FDA Repays Industry by Rushing Risky Drugs to Market

As pharma companies underwrite three-fourths of the FDA’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits.

Follow ProPublica

Our Latest Stories

Current site Current page